Patients with myelodysplastic syndromes (MDS) who undergo allogeneic hematopoietic stem cell transplantation (allo-HSCT) are older and face worse outcomes compared with non-MDS patients ...

Bexmarilimab and Vidaza achieved high response rates in higher-risk myelodysplastic syndrome, meeting the phase 2 BEXMAB trial's primary endpoint. The treatment demonstrated a 63% objective response ...

Myelodysplastic syndromes (MDS) comprise the most common malignant blood disorder. MDS are increasing in frequency owing to an ageing population and increased awareness of these diseases.

Roughly one in 14 people with lower-risk myelodysplastic syndromes (LR-MDS) have an infection in the first year after diagnosis, according to a study published online April 10 in Haematologica.

The myelodysplastic syndromes (MDS) are disorders of the haematopoietic stem cells in the bone marrow, that result in a decreased production of blood cells. MDS mainly affects patients aged 70 and ...

Several people in my family had myelodysplastic syndromes. I used Mayo Clinic as my source. Bone marrow normally makes new immature blood cells that mature over time. There are three types of ...

These tips can help you better manage MDS fatigue. Myelodysplastic syndromes (MDS) is a type of cancer that shows up as a group of conditions affecting your bone marrow and blood. “Myelo ...

TUESDAY, April 22, 2025 (HealthDay News) — Roughly one in 14 people with lower-risk myelodysplastic syndromes (LR-MDS) have an infection in the first year after diagnosis, according to a study ...

Faron is planning for a Phase III trial, pending U.S Food and Drug Administration (FDA) End of Phase II meeting Feedback TURKU, FINLAND - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON ...

Skin rashes can have many different causes, one of which is medications. The symptoms of drug-induced skin reactions can range from a mild itchy rash to more serious reactions, such as widespread ...